Back to trial detailsIntake questionnaire
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Applying to University of Washington Fred Hutchinson Cancer Center · Seattle, Washington
Answer a few short questions to share with the research team.
0 of 3 answered